ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes
Pediatric Diabetes(2022)
摘要
E. Cengiz is a scientific advisor for Eli Lilly, Novo Nordisk, Adocia and Arecor. TD has received speaker's honoraria and research support from or has consulted for Astra Zeneca, Bayer, Boehringer, Dexcom, Eli Lilly, Lifescan, Medtronic, Novo Nordisk, Provention Bio, Roche, Sanofi, Ypsomed and is a shareholder of Drea Med Ltd. TA, JF, DB, SH, MP, E. Codner have no disclosures.
更多查看译文
关键词
insulin treatment,diabetes,clinical practice consensus guidelines,adolescents
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要